Get the Stockscreener App
54.07
3.12%
-1.74
After Hours:
49.68
-4.39
-8.12%
Tempus Ai Inc stock is traded at $54.07, with a volume of 5.61M.
It is down -3.12% in the last 24 hours and up +14.10% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$55.81
Open:
$56.05
24h Volume:
5.61M
Relative Volume:
1.05
Market Cap:
$9.70B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-38.43
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
+5.81%
1M Performance:
+14.10%
6M Performance:
-34.27%
1Y Performance:
+0.00%
1-Day Range:
$53.10
$56.41
1-Week Range:
$48.91
$56.41
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI Q1 Earnings Call Highlights - Yahoo Finance
Tempus AI Earnings Call Highlights Growth and Profitability - TipRanks
Tempus AI : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Tempus AI : 1Q26 Corporate Deck - marketscreener.com
Tempus AI (TEM) Q1 2026 Earnings Transcript - The Globe and Mail
Tempus AI Lifts 2026 Outlook on Robust Q1 Growth - TipRanks
Why Tempus AI Stock Is Sliding Before Earnings - TipRanks
Transcript : Tempus AI, Inc., Q1 2026 Earnings Call, May 05, 2026 - marketscreener.com
Tempus AI falls on wider loss despite revenue beat By Investing.com - Investing.com Nigeria
Pelosi, Wood-Backed Tempus AI In Focus After Q1 ResultsTempus AI (NASDAQ:TEM) - Benzinga
Earnings call transcript: Tempus AI sees robust revenue growth despite EPS miss in Q1 2026 - Investing.com
Tempus AI falls on wider loss despite revenue beat - Investing.com
Tempus AI reported revenue of $348 million in Q1 2026, representing a year-over-year increase of 36.1% - 富途牛牛
Tempus AI Inc reports results for the quarter ended March 31Earnings Summary - TradingView
(TEM) Tempus AI Expects Full Year 2026 Revenue Range $1.59B$1.60B, vs. FactSet Est of $1.59B - marketscreener.com
Tempus AI Q1 Non-GAAP Loss Narrows, Revenue Rises; Revises 2026 Revenue Guidance - marketscreener.com
Tempus AI drops after reporting better-than-expected Q1 results - Sherwood News
Earnings Flash (TEM) Tempus AI, Inc. Reports Q1 Revenue $348.1M, vs. FactSet Est of $345.4M - marketscreener.com
Earnings Flash (TEM) Tempus AI, Inc. Posts Q1 Adjusted Loss $0.13 per Share, vs. FactSet Est of $-0.20 - marketscreener.com
Tempus AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Tempus AI (NASDAQ: TEM) grows Q1 revenue but reports $125,919K net loss - Stock Titan
Tempus AI (NASDAQ: TEM) posts 36% Q1 revenue growth and raises 2026 outlook - Stock Titan
Tempus Reports First Quarter 2026 Results - The Joplin Globe
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Artificial Intelligence Stocks To ConsiderMay 5th - MarketBeat
Tempus AI earnings up next: Can growth quiet reimbursement fears? - Investing.com
Tempus AI earnings up next: Can growth quiet reimbursement fears? By Investing.com - Investing.com Canada
Ex-lab worker sues Tempus AI, says HR turned on her after report - hcamag.com
Vanguard Group Inc. Grows Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. $TEM Shares Bought by Pictet Asset Management Holding SA - MarketBeat
Does Tempus AI’s (TEM) USC Partnership Reveal the Real Leverage in Its Data-Moat Strategy? - simplywall.st
Best Artificial Intelligence Stocks To ConsiderMay 3rd - MarketBeat
Why Tempus AI (TEM) Is Up 5.5% After Major USC Precision-Medicine Data Partnership News - Yahoo Finance
Hussman Strategic Advisors Inc. Purchases 21,000 Shares of Tempus AI, Inc. $TEM - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Artificial Intelligence Stocks To Keep An Eye OnMay 2nd - MarketBeat
Northwestern Medicine Selects Tempus to Expand Genomic Testing - The National Law Review
Tempus AI (TEM) Stock Named to TIME’s Most Influential Health Companies of 2026 - MEXC
Tempus AI (TEM) Stock Gains Recognition on TIME’s 2026 Health Influencer List - MEXC Exchange
Best Artificial Intelligence Stocks Worth WatchingMay 1st - MarketBeat
Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus - TechStock²
Tempus AI (TEM) Partners with Keck Medicine of USC to Integrate AI Across Healthcare Network - Insider Monkey
TEM Stock Price, Quote & Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock - MarketBeat
Tempus AI Faces Class Action Cases for Collection of Genetic Information in Acquisition - The National Law Review
TEM Stock Price Prediction 2025-2026 | Tempus AI, Inc. Class A Common Stock Forecast | 24/7 Wall St. - 24/7 Wall St.
Tempus AI(TEM.US) 10% Shareholder Sells US$8.5 Million in Common Stock - Moomoo
Tempus AI (TEM) CEO’s entities sell 166,250 shares under Rule 10b5-1 plan - Stock Titan
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? - Insider Monkey
5 Best Up and Coming Stocks with Highest Upside Potential - Insider Monkey
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now? - Yahoo Finance
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.92%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):